[1] |
Song YX, Yue ZY, Wang ZN, et al. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation[J]. Mol cancer, 2011(10): 1.
|
[2] |
Song KH, Li T, Owsley E, et al. A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes[J]. J Lipid Res, 2010, 51(8): 2223-2233.
|
[3] |
Luna JM, Scheel TK, Danino T, et al. Hepatitis C virus RNA functionally sequesters miR-122[J]. Cell, 2015, 160(6): 1099-1110.
|
[4] |
Jopling CL, Yi M, Lancaster AM, et al. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA[J]. Science, 2005, 309(5740): 1577-1581.
|
[5] |
Jopling CL, Schutz S, Sarnow P. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome[J]. Cell Host Microbe, 2008, 4(1): 77-85.
|
[6] |
Thibault PA, Huys A, Amador-Cañizares Y, et al. Regulation of hepatitis C virus genome replication by Xrn1 and microRNA-122 binding to individual sites in the 5' untranslated region[J]. J Virol, 2015, 89(12): 6294-6311.
|
[7] |
Pang PS, Pham EA, Elazar M, et al. Structural map of a microRNA-122: hepatitis C virus complex[J]. J Virol, 2012, 86(2): 1250-1254.
|
[8] |
Machlin ES, Sarnow P, Sagan SM. Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex[J]. Proc Natl Acad Sci U S A, 2011, 108(8): 3193-3198.
|
[9] |
Shimakami T, Yamane D, Jangra RK, et al. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex[J]. Proc Natl Acad Sci U S A, 2012, 109(3): 941-946.
|
[10] |
Roberts AP, Doidge R, Tarr AW, et al. The P body protein LSm1 contributes to stimulation of hepatitis C virus translation, but not replication, by microRNA-122[J]. Nucleic Acids Res, 2014, 42(2): 1257-1269.
|
[11] |
Kumar S, Chawla YK, Ghosh S, et al. Severity of hepatitis C virus (genotype-3) infection positively correlates with circulating microRNA-122 in patients sera[J]. Dis Markers, 2014: 435476.
|
[12] |
Shibata C, Ohno M, Otsuka M, et al. The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels[J]. Virology, 2014(462/463): 42-48.
|
[13] |
Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA[J]. N Engl J Med, 2013, 368(18): 1685-1694.
|
[14] |
Chen Y, Shen A, Rider PJ, et al. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication[J]. FASEB J, 2011, 25(12): 4511-4521.
|
[15] |
Wang S, Qiu L, Yan X, et al. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity[J]. Hepatology, 2012, 55(3): 730-741.
|
[16] |
Qiu L, Fan H, Jin W, et al. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV[J]. Biochem Biophys Res Commun, 2010, 398(4): 771-777.
|
[17] |
Hsu SH, Wang B, Kota J, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver[J]. J Clin Invest, 2012, 122(8): 2871-2883.
|
[18] |
Tsai WC, Hsu SD, Hsu CS, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis[J]. J Clin Invest, 2012, 122(8): 2884-2897.
|
[19] |
Bai S, Nasser MW, Wang B, et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib[J]. J Biol Chem, 2009, 284(46): 32015-32027.
|
[20] |
Fornari F, Gramantieri L, Giovannini C, et al. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells[J]. Cancer Res, 2009, 69(14): 5761-5767.
|
[21] |
Wu Q, Liu HO, Liu YD, et al. Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity[J]. J Biol Chem, 2015, 290(2): 1170-1185.
|
[22] |
Lin CJ, Gong HY, Tseng HC, et al. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines[J]. Biochem Biophys Res Commun, 2008, 375(3): 315-320.
|
[23] |
Wong CC, Au SL, Tse AP, et al. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis[J]. PloS one, 2014, 9(12): e115036.
|
[24] |
Wang B, Hsu SH, Wang X, et al. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2[J]. Hepatology, 2014, 59(2): 555-566.
|
[25] |
Spaniel C, Honda M, Selitsky SR, et al. microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection[J]. PloS one, 2013, 8(10): e76867.
|